|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/30 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/40 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/55 | (2006.01) | ||
| A61K 47/50 | (2017.01) |
| (11) | Number of the document | 3186283 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15753700.2 |
| Date of filing the European patent application | 2015-08-25 | |
| (97) | Date of publication of the European application | 2017-07-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-25 |
| (46) | Date of publication of the claims translation | 2020-03-10 |
| (86) | Number | PCT/EP2015/069399 |
| Date | 2015-08-25 |
| (87) | Number | WO 2016/030350 |
| Date | 2016-03-03 |
| (30) | Number | Date | Country code |
| 14182778 | 2014-08-29 | EP |
| (72) |
UMANA, Pablo, CH
KLEIN, Christian, CH
NICOLINI, Valeria G., CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kombinuotoji terapija į naviką nutaikytais IL-2 imunocitokinais ir antikūnais prieš žmogaus PD-L1 |
| COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1 |
| Payment date | Validity (years) | Amount | |
| 2022-08-11 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-08-25 |